期刊
DIABETOLOGIA
卷 56, 期 1, 页码 10-21出版社
SPRINGER
DOI: 10.1007/s00125-012-2737-4
关键词
Adipose tissue; AFABP; Cardiovascular disease; Insulin resistance; Metabolic syndrome; Obesity; Review
资金
- Deutsche Forschungsgemeinschaft (DFG) [KFO 152, FA476/4-1]
- Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001, K7-3, K7-9, K7-31]
- Deutsche Hochdruckliga e.V.
Adipocyte fatty acid binding protein (AFABP, also known as aP2 and FABP4) has recently been introduced as a novel fat-derived circulating protein. AFABP serum concentrations are positively correlated with markers of the metabolic syndrome and vascular disease in various cross-sectional and interventional studies. Furthermore, a small set of prospective studies indicates that high AFABP serum levels at baseline predict the risk for metabolic and vascular morbidity and mortality. Studies in Afabp (also known as Fabp4) knockout mice and AFABP inhibitor-treated animals suggest that total AFABP promotes insulin resistance, hypertriacylglycerolaemia and atherosclerosis by ligand/ligand delivery, as well as ligand-independent mechanisms. In contrast, the pathophysiological significance of circulating AFABP and the mechanisms leading to its release remain to be established. The current review summarises recent findings on the regulation and potential role of AFABP in metabolic and vascular disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据